Correction: Yunita et al. Scoping Review: The Role of Tocotrienol-Rich Fraction as a Potent Neuroprotective Agent. Int. J. Mol. Sci. 2025, 26, 7691 Authors: Elvira Yunita, Muhammad Luqman Nasaruddin, Nur Zuliani Ramli, Mohamad Fairuz Yahaya, Hanafi Ahmad Damanhuri Published: 2026 Missing Citation In the original publication, Borsche M et al. was not cited. Previous paper (No. 66-Sliter, D.A. et al. was retracted by the publisher) [1]. So, the authors want to change the retracted paper [66] with a new reference. The citation has now been inserted in the Discussion Section, Fourth Paragraph and should read: Likewise, in PD patients, a robust inflammatory response including IL-6, was observed following PRKN/PINK1, which promoted mtDNA release and mitochondrial damage [66]. Original ref. 66: Sliter, D.A.; Martinez, J.; Hao, L.; Chen, X.; Sun, N.; Fischer, T.D.; Burman, J.L.; Li, Y.; Zhang, Z.; Narendra, D.P.; et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 2018, 561, 258–262. https://doi.org/10.1038/s41586-018-0448-9. New ref. 66: Borsche, M.; König, I.R.; Delcambre, S.; Petrucci, S.; Balck, A.; Brüggemann, N.; Zimprich, A.; Wasner, K.; Pereira, S.L.; Avenali, M.; et al. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism. Brain 2020, 143, 3041–3051. https://doi.org/10.1093/brain/awaa246. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.